Skip to main content
. 2013 Dec 15;8(35):3269–3274. doi: 10.3969/j.issn.1673-5374.2013.35.001

Figure 2.

Figure 2

Cell proliferation after treatment with different concentrations of alpha-synuclein.

(A) Control, (B) alpha-synuclein 50 nmol/L, (C) alpha-synuclein 100 nmol/L, (D) alpha-synuclein 1 μmol/L. 4’,6-Diamidino-2-phenylindole (DAPI) staining (blue), 5-bromo-2’-deoxyuridine (BrdU) staining (red), × 100. Proportion of BrdU-positive cells was decreased after 24 hour alpha-synuclein treatment in neuronally-differentiated SH-SY5Y cells.